drugset / Trial / NCT05729932
Cannabis and Opioid Use Disorder
Phase 1
Recruiting
15 enrolled
Shanna Babalonis, PhD
National Institute on Drug Abuse (NIDA) · collab
RandomizedCrossoverTriple-blindBasic science
Summary
This study plans to enroll participants with opioid use disorder who are not currently seeking treatment to assess the effects of cannabis on opioid withdrawal and other related outcomes.
Timeline
- Start
- 2024-09-10
- Primary completion
- 2027-06-30
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabis | Traditional medicine (herbal / TCM) | — | Inhaled |